Samya G. Obaji

Cardiff, WLS, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis.

Emicizumab use in females with moderate or mild hemophilia A without factor VIII inhibitors who warrant prophylaxis.

Journal: Research and practice in thrombosis and haemostasis

Published: April 17, 2023

Outcomes and management of pregnancy in women with bleeding disorder of unknown cause.

Outcomes and management of pregnancy in women with bleeding disorder of unknown cause.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 27, 2022

Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors' Organisation centers for patients with unclassified bleeding disorders.

Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors' Organisation centers for patients with unclassified bleeding disorders.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 17, 2021

Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies.

Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: May 11, 2021

The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles.

The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesicles.

Journal: PloS one

Published: June 11, 2020

Clinical phenotype of severe and moderate haemophilia: Who should receive prophylaxis and what is the target trough level?

Clinical phenotype of severe and moderate haemophilia: Who should receive prophylaxis and what is the target trough level?

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 04, 2020

Diagnostic work up of patients with increased bleeding tendency: Comment.

Diagnostic work up of patients with increased bleeding tendency: Comment.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 02, 2020

Phospholipid membranes drive abdominal aortic aneurysm development through stimulating coagulation factor activity.

Phospholipid membranes drive abdominal aortic aneurysm development through stimulating coagulation factor activity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 05, 2019

Mycophenolate mofetil as adjunctive therapy in acquired haemophilia A.

Mycophenolate mofetil as adjunctive therapy in acquired haemophilia A.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: September 21, 2018

Phenotype description and response to thrombopoietin receptor agonist in DIAPH1-related disorder.

Phenotype description and response to thrombopoietin receptor agonist in DIAPH1-related disorder.

Journal: Blood advances

Published: May 03, 2018

Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis.

Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis.

Journal: Science signaling

Published: November 30, 2017

Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding.

Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding.

Journal: Blood

Published: March 30, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026